USPTO serial 98910926
GUIDEPOINT
Reviewed by CopyMark Law Group
Status 653
- Filing date
- Status date
- Registration date
- —
- Examiner
- SENSOR, JAMES EARL
- Law office
- TMO LAW OFFICE 129
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with GUIDEPOINT?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Foster City, CA, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Ryan S. Hilbert
Ryan S. Hilbert Holley & Menker PAPO Box 331937Atlantic Beach, FL 32233United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Medical diagnostic tests comprised of assays and reagents that test for the presence of medical biomarkers present in human blood and body fluids by applying advanced analytics; Medical diagnostic tests comprised of assays and reagents that test for the presence of medical biomarkers present in human blood and body fluids by applying machine learning technology; Medical diagnostic test strips for blood analysis, urine analysis, saliva analysis, water analysis, and liquid biopsy; Diagnostic assays, reagents, enzymes, and nucleotides for medical and clinical purposes, namely, for testing blood and body fluids, all of the preceding excluding pharmacy services and retail sales of prescription and over-the-counter pharmaceuticals of third parties | ACTIVE | — |
| 010 | Blood collection kit comprised of blood collecting tubes; Blood testing apparatus; Diagnostic apparatus for medical purposes, namely, diagnostic kits consisting primarily of probes, buffers and reagents for use in liquid biopsy testing; Diagnostic tests comprising medical apparatus and instruments, namely, liquid biopsy testing systems comprised of diagnostic apparatus for medical purposes used in medical laboratories for testing blood and body fluids; Medical diagnostic testing kits comprised primarily of sterile medical specimen collection tools in the nature of lancets, saliva collection tubes, collection cards, and swabs for the collection of blood, urine, saliva, and feces for use in testing and for monitoring various medical conditions, and also including printed instructions and return shipping packaging, all of the preceding excluding pharmacy services and retail sales of prescription and over-the-counter pharmaceuticals of third parties | ACTIVE | — |
| 042 | Laboratory testing services, namely, clinical processing of medical diagnostic testing kits; Providing temporary use of non-downloadable software for use in creating, displaying, sharing and storing test results in the fields of cancer and prenatal, cardiovascular and autoimmunity anomalies, disorders and diseases; all of the preceding excluding pharmacy services and retail sales of prescription and over-the-counter pharmaceuticals of third parties | ACTIVE | — |
| 044 | Medical testing for diagnostic or treatment purposes; Medical diagnostic testing, monitoring, and reporting services; Consulting services in the fields of diagnostic medical testing; Providing medical consultancy and advisory services; Providing medical testing services in the fields of cancer and prenatal, cardiovascular and autoimmunity anomalies, disorders and diseases for diagnostic or treatment purposes; Medical testing services, namely, diagnostic testing services for detecting cancer and prenatal, cardiovascular and autoimmunity anomalies, disorders and diseases by identifying and analyzing biomarkers for diagnostic or treatment purposes; Providing medical screening, detection being medical testing, and monitoring services for cancer and prenatal, cardiovascular and autoimmunity anomalies, disorders and diseases; Medical analysis services for diagnostic and treatment purposes provided by medical laboratories, namely, clinical processing of medical diagnostic testing kits, all of the preceding excluding pharmacy services and retail sales of prescription and over-the-counter pharmaceuticals of third parties | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 14, 2026 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Jul 14, 2026 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Jul 14, 2026 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Jun 16, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 16, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 16, 2026 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Feb 20, 2026 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Feb 20, 2026 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Feb 20, 2026 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Jan 23, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 23, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 23, 2026 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Sep 18, 2025 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Sep 18, 2025 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Sep 18, 2025 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Aug 21, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 21, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 21, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 9, 2025 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 9, 2025 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 9, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 5, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 27, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 18, 2024 | NWAP | NEW APPLICATION ENTERED | — |